Clinical Trials Directory

Trials / Completed

CompletedNCT03079648

Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride

A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Blood Triglyceride.

Detailed description

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Angelica gigas N. extract or a placebo group. Fasting triglyceride profiles before and after the intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAngelica gigas N. extractcapsules (2cap/d, 1,000mg/d) for 12 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo for 12 weeks

Timeline

Start date
2017-03-02
Primary completion
2018-04-06
Completion
2018-04-06
First posted
2017-03-14
Last updated
2019-12-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03079648. Inclusion in this directory is not an endorsement.